Bringing together researchers, clinicians and educators with the vision to create and disseminate new knowledge on pain to optimise patient outcomes.
The Sydney Pain Consortium is a multidisciplinary network of scientists, clinicians and educators that provides a leading voice in pain research that translates into optimal clinical service delivery nationally and internationally. The fostering of existing and the creating of new collaborations is a core role of the Sydney Pain Consortium
The Sydney Pain Consortium’s focus is to determine the underlying mechanisms responsible for transient and persistent pain and medication dependency and to translate these findings into clinical practice, education, policy and community awareness.
Elena Bagley leads a laboratory focused on synaptic dysfunction. She uses patch-clamp electrophysiology, optogenetics, immunohistochemistry and biochemical assays to study synaptic properties involved in physiological or pathophysiological processes. Of particular interest are the synaptic changes or plasticity that may be responsible for chronic pain states, addiction and anxiety disorders.
Claire Ashton-James is a Social Psychologist whose research aims to evaluate and improve healthcare delivery for the benefit of both patients (treatment outcomes) and clinicians (wellbeing and job satisfaction).
Jim Elliott is the Academic Director of the Kolling Institute, Professor and Academic Director, Allied Health and Public Health - The Northern Precinct and Professor in the School of Health Sciences, Faculty of Medicine and Health, Sydney University.
His research is focused on understanding the pathophysiological mechanisms underlying the transition from acute to chronic pain following traumatic injury.
Specifically, he utilises structural and advanced magnetic resonance imaging applications to quantify the temporal development of altered spinal cord physiology and muscle degeneration as potential cellular and molecular substrates of persistent pain-related disability
Susanna Park is an Associate Professor in Neuroscience, School of Medical Sciences based at the Brain and Mind Centre, University of Sydney.
She has been awarded competitive research funding in projects across the clinical neurosciences, with research involvement in toxic, metabolic, immune-mediated and painful neuropathies and motor neuron diseases.
She has expertise in multidisciplinary peripheral neuropathy research, leading studies examining clinical translation, assessment strategies, treatment and risk factors for chemotherapy-induced peripheral neuropathy.
Noemi Meylakh is an early career researcher (ECR) investigating the underlying neurobiology of episodic and chronic migraine.
Her current research projects are focused on central changes associated with chronic migraine, particularly the activity of the hypothalamus and endogenous analgesic circuit.
Of further interest, is the nature of the activity in these regions following successful and unsuccessful CGRP inhibitor treatment